FDA Staff Has Concerns Over Endo Testosterone Replacement
An application for a new testosterone replacement drug by Endo Pharmaceuticals has serious safety risks that may outweigh its benefits, according to a report by U.S. Food and Drug Administration reviewers...To view the full article, register now.
Already a subscriber? Click here to view full article